4
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Immunosuppressive and Antiproliferative Effects of Somatostatin Analog SMS 201–995

, , , , , & show all
Pages 283-297 | Received 30 Nov 1994, Published online: 07 Jul 2009

References

  • Agro A., Padol I., Stanisz A. M. Immunomodulatory activities of the somatostatin analogue BIM 23014c: effects on murine lymphocyte proliferation and natural killer activity. Regulatory Peptides 1991; 32: 129–139
  • Azad N., Agrawal L., Emanuele M. A., Kelley M. R., Mohagheghpour N., Lawrence A. M., Emanuele N. V. Neuroimmunoendocrinology. American Journal of Reproductive Immunology 1991; 26: 160–172
  • Berridge M. J. Inositol lipids and cell proliferation. Biochimica et Biophysica Acta 1987; 907: 33–45
  • Berridge M. J. Inositol triphosphate and calcium signalling. Nature 1993; 361: 315–325
  • Bhathena S. J., Louie J., Schechter G. P., Redman R. S., Wahl L., Recant L. Identification of human mononuclear leukocytes and glucagon. Diabetes 1981; 30: 127–130
  • Blalock J. E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiological Reviews 1989; 69: 1–32
  • Brothier P., Boumsell B., Gelin C., Bernard A. T cell activation via CD2 (T.gp50) molecules: accessory cells are required to trigger T cell activation via CD2‐D66 plus CD2–9.6/T11 epitopes. The Journal of Immunology 1985; 135: 1624–1631
  • Cunningham A. J., Szenberg A. Further improvements in the plaque technique for detecting single antibody forming cells. Immunology 1968; 14: 599–600
  • Dumont J. F., Jauniaux J. C., Roger P. P. The cyclicAMP‐ mediated stimulation of cell proliferation. Trends in Biochemical Sciences 1989; 14: 67–71
  • Ford W. L., Burr W., Simonsen. A lymph‐node weight assay for graft versus host activity of rat lym‐phoid cells. Transplantation 1970; 10: 258–266
  • Goetzl E. J., Adelman D. C., Sreedharan S. P. Neuroimmunology. Advances in Immunology 1990; 48: 161–190
  • Hicrowski M. T., Liebow C., du Sapin K., Schally A. V. Stimulation of somatostatin dephosphory‐lation of membrane protein in pancreatic cancer MIA paCA‐2 cell line. Federation of European Biochemical Society letters 1985; 179: 252–256
  • Hinterberger W., Cerny C., Kinast H., Pointner H., Tragl K. H. Somatostatin reduces the release of colony‐ stimulating activity (CSA) from PHA‐activated mouse spleen lymphocytes. Experientia 1978; 34: 860–862
  • Koch B. D., Dorflinger L. J., Schonbrunn A. Pertussis toxin blocks both cyclic AMP‐mediated and cyclic AMP‐independent activation of somatostalin. Journal of Biological Chemistry 1985; 260: 13138–13145
  • Koch B. D., Schonbrunn A. Characterization of the cyclic AMP—independent actions of somatostatin in GH cells. An increase in potassium conductance initiates somatostatin‐induced inhibition of prolactin secretion. Journal of Biological Chemistry 1988; 263: 226–234
  • Lachowicz A., Stepien H., Kunert‐Radek J., Pavlikowski M. Effect of somatostatin on inositol‐1,4,5‐triphosphatc content in mouse spleen lymphocytes. Comparative Biochemical Physiological Acta 1992; 101: 661–664
  • Liebow C., Serrano C., Reilly M., Schally A. V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proceedings of National Academy of Science USA 1989; 86: 2003–2007
  • Mollard P., Vacher P., Duty B., Barker J. L. Somatostatin blocks Ca2* action potential activity in prolactin‐ secreting pituitary tumor cells through coordinate action on K+ and Ca2+ conductances. Endocrinology 1988; 123: 721–732
  • Milin Č, Radošević‐Stašić B., Kirigin M., Hinić V., Rukavina D., Berggren P. O., Efendić S. Somatostatin promotes accumulation of phospholipids in regenerating liver tissue of rats. Bioscience Reports 1991; II: 1–6
  • O'Flynn K., Krensky A. M., Beverley P. C. L., Burakoff S. J., Linch D. C. Phytohaemagglutinin activation of T cells through the sheep red blood receptor. Nature 1985; 313: 686–687
  • Payan D. G., McGillis J. P., Renold F. K., Mitsuhashi M., Goetzl E. J. Neuropeptide modulation of leukocyte function. Annals New York Academy of Science 1986; 496: 182–192
  • Payan D. G., Hess C. A., Goetzl E. J. Inhibition by somatostatin of the proliferation of T lymphocytes and Molt‐4 lymphoblasts. Cellular Immunology 1984; 84: 433–438
  • Polic L., Radošević‐Stašić B., Rukavina D. The action of somatostatin on the lymphatic tissue in rats. Lugoslavica Physiologica et Pharmacologica Acta 1983; 19: 164–167
  • Polić I., Radošević‐Stašić B., Rukavina D., Efendić S. Humoral immune response of mice and rats treated with somatostatin. Periodicum Biologorum 1983; 85: 101–102
  • Polić I., Radošević‐Stašić B., Rukavina D., Efendić S. Local GVHR in F1 hybrid mice after the treatment of donors with somatostatin. Periodicum Biologorum 1986; 88: 87–89
  • Polić I., Radošević‐Stašić B., Rukavina D., Efendić S. The modulation of immunological potential of splenocytes in induction of local GVHR by somatostatin. Annals of New York Academy of Science 1986; 496: 303–307
  • Radošević‐Stašić B., Polić L., Rukavina D., Efendić S. Inhibition of local graft‐versus‐host reaction with somatostatin in mice. IRCS Journal of Medical Science 1983; II: 1097
  • Radošević‐Stašić B., Êuk M., Rukavina D. Immunomodulation by somatostatin. Periodicum Biologorum 1991; 93: 131–139
  • Selvaraj P., Plunkett M. L., Dustin M., Sanders M. E., Shaw S., Springer T. A. The T lymphocytes glycoprotein CD2 binds the cell surface ligand LFA‐3. Nature 1987; 326: 400–403
  • Sirinek L. P., O'Dorisio M. S. Modulation of immune function by intestinal neuropeplides. Acta Oncologica 1991; 30: 509–517
  • Sreedharan S. P., Kodama K. T., Peterson K. E., Goetzl E. J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. Journal of Biological Chemistry 1989; 264: 949–952
  • Stanisz A. M., Befus D., Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen. Journal of Immunology 1986; 136: 152–156
  • Stanisz A. M., Scicchitano R., Payan D. G., Bienenstock J. In vitro studies of immunoregulation by substance P and somatostatin. Annals New York Academy of Science 1986; 496: 217–226
  • Thomas J. M., Meier‐Davis S. R., Hoffman B. B. Prolonged activation of inhibitory somatoslatin receptors increases adenylate cyclase activity in wild‐type and Gs alpha‐deficient (cyc‐) S49 mouse lymphoma cells. Cell‐Signal 1992; 4: 571–581
  • Vanhagen P. M., Krenning E. P., Reubi J. C., Mulder A. H., Bakker W. H., Oei H. Y., Lowenberg B., Lamberts S. W. Somatostatin analogue scintigraphy of malignant lymphomas. British Journal of Haematology 1993; 83: 75–79
  • Viguerie N., Tahiri‐Jouti N., Ayral A. M., Cambillau C., Scemama J. L., Bastie M. J., Knuhtsen S., Esteve J. P., Pradayrol L., Susini C., Vaysse N. Direct inhibitory effects of somatostatin analog SMS 201–995, on AR4–2J cell proliferation via pertussis toxin‐sensitive guanosine triphosphate‐binding protein‐independent mechanism. Endocrinology 1989; 124: 1017–1025
  • Yang S. Y., Chouaib S., Dupont B. A common pathway for T lymphocyte activation involving both the CD3‐Ti complex and CD2 sheep erythrocyte receptor determinants. The Journal of Immunology 1986; 137: 1097–1100

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.